Home/Akaal Pharma/B. S. Sandhu

BS

B. S. Sandhu

Chairman of the Board, Co‑Founder, Principal Investor

Therapeutic Areas

Immunology Dermatology Neurology

Akaal Pharma Pipeline

Drug	Indication	Phase
Takp-119	Atopic dermatitis (pruritus)	Phase 2
Oakp-11	Autoimmune diseases; neuropathic pain	Phase 1

Leadership Team at Akaal Pharma

Tony Rajic, PhD

Chief Executive Officer

Gurmit S. Gill, PhD

Vice President Research & Development

Bobby Sandhu, MA

Chief Financial Officer

View full Akaal Pharma profile